Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page
- CheckyesterdayChange DetectedThe study locations list was updated to 13 sites, removing one previously listed location and reducing the total from 14 to 13.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a newer site deployment while the visible content remains the same.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 was removed, indicating a platform/software update for the page. This appears to be a templating or system update with no visible changes to the study content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a new revision release. This reflects a small administrative update to the page's revision history rather than changes to study content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows Revision: v3.6.2, updating the revision tag to reflect a software update rather than a change to study details.SummaryDifference0.1%

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.